Actively Recruiting
Project DEDUCE: Digital Envirotyping to Develop Understanding of Cigarette Smoking and the Environment
Led by Duke University · Updated on 2026-05-12
600
Participants Needed
1
Research Sites
203 weeks
Total Duration
On this page
Sponsors
D
Duke University
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Tobacco use is a chronic relapsing condition. That is, even with state-of-the-art treatment, \>70% of smoking cessation attempts end in a return to regular smoking. Research demonstrates that everyday environments associated with smoking trigger craving for cigarettes, provoke smoking, and lead to relapse. However, despite this knowledge, understanding of environmental correlates of smoking has been limited by a reliance on self-report, leading to imprecise information about the physical environments in which people live. To overcome this challenge, the research team has pioneered the development of digital envirotyping, which uses digital tools (e.g., sensors, cameras, artificial intelligence) to efficiently and accurately characterize and categorize environments with the goal of identifying environmental markers of behavior and health. Foundational to the digital envirotyping research is computer vision (CV), a type of artificial intelligence (AI) that enables computer systems to recognize objects and scenes in digital images, mimicking how humans perceive and understand visual information. With CV researchers can extract detailed and accurate information (i.e., objects and location types) about the everyday environments of people who smoke (PWS) and relate that information to smoking behavior. After validating the use of CV, the researchers used CV to develop enviromarkers of relapse risk. Importantly, they identified a novel enviromarker in which people at greater risk for relapse when they quit are exposed to a more consistent level of environment-related smoking risk as they move between their smoking and nonsmoking environments. Research is now needed to advance digital envirotyping and enviromarker development in the field of tobacco addiction. The study will recruit a diverse, national sample of n=500 adults who are interested in quitting smoking. For two weeks prior to quitting, they will undergo photoEMA in which they will take two pictures of their current environment when they smoke, and randomly 10 times per day resulting in \>300,000 images total. Cessation will be supported by nicotine replacement therapy (i.e., nicotine patch). The primary clinical outcome will be days to relapse. Specific aims are to (1) further develop, refine, and validate methods for efficient digital envirotyping at scale, (2) leverage CV and AI approaches to develop enviromarkers of smoking relapse, and (3) conduct analyses to increase understanding of environmental smoking risk in women and individuals with low socioeconomic status.
CONDITIONS
Official Title
Project DEDUCE: Digital Envirotyping to Develop Understanding of Cigarette Smoking and the Environment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 21 years of age or older
- Smoke at least 10 cigarettes per day of a brand delivering 0.5 mg nicotine
- Smoking daily for at least 2 years with a stable smoking pattern for the past 6 months
- Intend to quit smoking and set a target quit date within the next month
- Have an iPhone or Android smartphone capable of running the photoEMA and iCO software
You will not qualify if you...
- Pregnant, breastfeeding, or planning to become pregnant during the study
- Currently receiving smoking cessation treatment or using smoking cessation products
- Regular use (more than 9 days per month) of non-cigarette nicotine products such as cigarillos or e-cigarettes
- Expecting major life changes during the study (e.g., new job, birth of a child)
- Have unstable medical conditions
- Have contraindications for nicotine replacement therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Duke University Medical Center
Durham, North Carolina, United States, 27706
Actively Recruiting
Research Team
L
Laura Van Althuis, MHA
CONTACT
F
Francis J. McClernon, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here